-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
03 Dec 2025 09:48 CET
Issuer
SARTORIUS STEDIM BIOTECH
|
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech S.A. - 13400 Aubagne, France
DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Article L 233-8-II of the Code of commerce and article 223-6 of the general regulations of the AMF
Designation of issuer
SARTORIUS STEDIM BIOTECH SA CS 91051 Z. I. Les Paluds Avenue de Jouques 13400 Aubagne
Regulatory filing PDF file File: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL |
| Language: | English |
| Company: | Sartorius Stedim Biotech SA |
| Avenue de Jouques | |
| 13781 Aubagne | |
| France | |
| Phone: | +33 44 284 5600 |
| E-mail: | sartorius.presse@sartorius.com |
| Internet: | www.sartorius.com |
| ISIN: | FR0013154002 |
| Euronext Ticker: | DIM |
| AMF Category: | Total number of voting rights and share capital / Information on the total number of voting rights and the number of shares making up the share capital |
| EQS News ID: | 2239624 |
| End of Announcement | EQS News Service |
2239624 03-Dec-2025 CET/CEST
KKGODDJWKBSTXGYLKINORFHX_20251130_SSB_IR_Declaration_voting_rights_en.pdf
Source
Sartorius Stedim Biotech SA
Provider
EQS Group
Company Name
SARTORIUS STED BIO, SARTORIUS STEDIM BIOTECH
ISIN
FR0013154002, FR0013154002
Symbol
DIM, 4DIM
Market
Euronext